Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03449095 · ClinicalTrials.gov registry record · NA
Understanding Alcohol Reward in Social Context
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 640
- Enrollment target
NCT03449095: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.
NCT03449095 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 640 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03449095, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 640 participants
- Enrollment target
Study Summary
In this study, the investigators examine whether emotional and social reward from alcohol varies depending on the social context of consumption.
Primary Outcome
Positive and negative emotion will be assessed during the laboratory beverage-administration session via self-report on the "8-item Mood Measure." This measure yields two subscales (positive emotion; negative emotion) each ranges from 1 to 6. For positive mood, higher value represents increased alcohol reward. For negative mood, lower value represents increased alcohol reward.
Interventions
- DRUG Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2017-11-04 |
| Est. Completion | 2023-07-05 |
| Phase | NA |
What the finished NCT03449095 record still lists
NCT03449095 is an interventional study that assigns participants to a tested intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower).
The record links to 0 conditions, and to 1 intervention - of which Alcohol is the first listed.
NCT03449095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03449095 about?
NCT03449095 is a clinical study titled "Understanding Alcohol Reward in Social Context". In this study, the investigators examine whether emotional and social reward from alcohol varies depending on the social context of consumption.
What is the current status of trial NCT03449095?
This trial is currently completed. It is a NA study. The enrollment target is 640 participants. The study started on 2017-11-04. Estimated completion is 2023-07-05.
What interventions are being tested in trial NCT03449095?
The interventions under investigation include: Alcohol (DRUG).
Who is sponsoring clinical trial NCT03449095?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03449095's enrollment target sits among peer trials
640 156th of 2000 higher than 1,844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI